Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of18F-Fluorodeoxyglucose Positron Emission Tomography
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
SUMMARY: During the past several years, it has become quite evident that positron emission tomography (PET) with 18 F-fluorodeoxyglucose (FDG) imaging can play a major role in the management of patients with suspected infection. Particularly, several groups have demonstrated that this powerful imaging methodology is very effective in the evaluation of osteomyelitis, infected prostheses, fever of unknown origin, and AIDS. In view of its extraordinary sensitivity in detecting disease activity and the ability to quantitate the degree of FDG uptake, PET might prove to be an appropriate modality for monitoring disease activity and evaluating response to therapy. FDG-PET has many advantages over existing imaging techniques for the diagnosis of infectious diseases. These include feasibility of securing diagnostic results within 1.5 to 2 h, excellent spatial resolution, and accurate anatomical localization of sites of abnormality. The availability of PET/computed tomography as a practical tool has further enhanced the role of metabolic imaging in many settings. In the future, this modality is very likely to be employed on a routine basis for detecting, characterizing, and monitoring patients with suspected and proven infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
WARBURN, O., & DICKENS, F. (1931) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193107000-00022 · Cited by 808 · cited 1×
“Based on the observations made by Warburg in the 1930s, it was known that malignant cells have significantly elevated glycolysis (132, 162).”
BackgroundThe Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.
Gordois, A., Scuffham, P., Shearer, A., Oglesby, A., & Tobian, J. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1790 · Cited by 734
Toxoplasmosis of the Central Nervous System in the Acquired Immunodeficiency Syndrome
Porter, S. B., & Sande, M. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272306 · Cited by 670 · cited 1×
“In AIDS patients, toxoplasmosis is the most common opportunistic infection, and the CNS is the most common site for this infection (128).”
BackgroundDual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
Zhuang, H. M., Pourdehnad, M., Lambright, E. S., Yamamoto, A., Lanuti, M., LI, P., Mozley, P. D., Rossman, M. D., Albelda, S. Μ., & Alavi, A. A. (2001) · PubMed · Cited by 657
Self-citationZhuang, H., & Alavi, A. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.29278 · Cited by 524 · cited 1×
“For example, FUO can be caused by sarcoidosis (29, 53, 97) and vasculitis (34, 47, 116, 138), both of which can be detected and characterized with FDG-PET at various stages of the disease (2, 10, 12, 16, 23, 39, 61, 91, 92, 109, 175, 183).”
BackgroundSelf-citation(1995) · PubMed · Cited by 474
Termaat, M. F. (2005) · The Journal of Bone and Joint Surgery (American) · doi:10.2106/jbjs.d.02691 · Cited by 377 · cited 1×
“(122) and 21% for chronic (158) osteomyelitis due to the poor”
BackgroundArnow, P. M., & Flaherty, J. P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07061-x · Cited by 322
A report from the international consensus on diagnosing and treating the infected diabetic foot
Lipsky, B. A., & The International Consensus Working Group on Diagnosing and Treating the Infected Diabetic Foot (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.453 · Cited by 291 · cited 1×
“Osteomyelitis comprises up to 33% of the diabetic foot infections and is often due to direct, contiguous contamination from the soft tissue lesions (96).”
BackgroundUptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
Lewis, P. J., & Salama, A. (1994) · PubMed · Cited by 287
Infection imaging using whole-body FDG-PET
Stumpe, K. D. M., Dazzi, H., Schaffner, A., & von Schulthess, G. K. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000277 · Cited by 266 · cited 1×
“(152) studied the results of 45 FDGPET scans from 39 patients with suspected infectious foci and noted 40 true-positive, 4 false-positive, and 1 false-negative result.”
BackgroundRadionuclide imaging in orthopedic infections
Palestro, C. J., & Torres, M. A. (1997) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(97)80006-2 · Cited by 246 · cited 1×
“and bone scintigraphy, have been employed to differentiate between these two conditions (85, 123, 142).”
BackgroundThe promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants.
Zhuang, H., Duarte, P. S., Pourdehnad, M., Maes, A., Acker, F. V., SHNIER, D., Garino, J. P., Fitzgerald, R. H., & Alavi, A. A. (2001) · PubMed · Cited by 236
Self-citationSugawara, Y., Braun, D. K., Kison, P. V., Russo, J. E., Zasadny, K. R., & Wahl, R. L. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050290 · Cited by 236 · cited 2×
“As such, in recent years, the range of applications for this technique has been broadened to include the evaluation of a variety of nonneoplastic disorders (56, 156).”
BackgroundBleeker‐Rovers, C. P., de Kleijn, E. M. H. A., Corstens, F. H. M., van der Meer, J. W. M., & Oyen, W. J. G. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1338-3 · Cited by 236 · cited 1×
“(17), FDG-PET imaging was employed to assess the cause of FUO.”
MethodBlockmans, D., Knockaert, D., Maes, A., De Caestecker, J., Stroobants, S., Bobbaers, H., & Mortelmans, L. (2001) · Clinical Infectious Diseases · doi:10.1086/318480 · Cited by 234 · cited 2×
“FDG-PET allows the identification of inflammatory and cancerous disorders as the underlying cause of FUO in most patients and has been shown to detect infectious and inflammatory disease processes that were undetected when conventional scintigraphic techniques or MRI was used (20, 35, 98, 106, 166, 170).”
Background18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer.
Kumar, R., Xiu, Y., Yu, J. Q., Takalkar, A. M., El-Haddad, G. E., Potenta, S. E., Kung, J. W., Zhuang, H., & Alavi, A. A. (2004) · PubMed · Cited by 233
Self-citationFukuchi, K., Ishida, Y., Higashi, M., Tsunekawa, T., Ogino, H., Minatoya, K., Kiso, K., & Naito, H. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.07.038 · Cited by 220 · cited 2×
“Fukuchi and colleagues evaluated the efficacy of FDG-PET compared to that of CT in 33 consecutive patients with suspected aortic prosthetic graft infection (48).”
BackgroundPET scanning and the human immunodeficiency virus-positive patient.
O'Doherty, M. J., Barrington, S. F., Campbell, M., Lowe, J., & Bradbeer, C. S. (1997) · PubMed · Cited by 213
Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings.
Guhlmann, A., Brecht-Krauss, D., Suger, G., Glatting, G., Kotzerke, J., Kinzl, L., & Reske, S. N. (1998) · Radiology · doi:10.1148/radiology.206.3.9494496 · Cited by 210 · cited 1×
“As such, in recent years, the range of applications for this technique has been broadened to include the evaluation of a variety of nonneoplastic disorders (56, 156).”
BackgroundIsasi, C. R., Lu, P., & Blaufox, M. D. (2005) · Cancer · doi:10.1002/cncr.21253 · Cited by 208 · cited 1×
“This methodology was used for the diagnosis, staging, treatment planning, and treatment monitoring of malignant disease (49, 68, 69, 88, 89, 180).”
MethodLove, C., Marwin, S. E., Tomas, M. B., Krauss, E. S., Tronco, G. G., Bhargava, K. K., Nichols, K. J., & Palestro, C. J. (2004) · PubMed · Cited by 207
Wahl, R. L., Henry, C. A., & Ethier, S. P. (1992) · Radiology · doi:10.1148/radiology.183.3.1584912 · Cited by 206 · cited 1×
“While hyperglycemia affects the accuracy of FDG-PET for evaluating suspected or confirmed malignancy, mild to moderate hyperglycemia ( 250 mg/dl of serum glucose) generally does not appear to have an observable effect when this technique is utilized to detect infection or inflammation (90, 95, 160, 184).”
MethodImaging bacterial infection with 99m Tc-ciprofloxacin (Infecton)
Britton, K. E., Wareham, D. W., Das, S. S., Solanki, K. K., Amaral, H., Bhatnagar, A., Katamihardja, A. H. S., Malamitsi, J., Moustafa, H. M., Soroa, V. E., et al. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.11.817 · Cited by 199 · cited 1×
“Other imaging techniques, such as radiolabeled antibody scintigraphy (42, 54, 104, 107, 119, 129) and radiolabeled antibiotic scintigraphy (22), have also been employed to detect FUO.”
MethodGuhlmann, A., Brecht-Krauß, D., Suger, G., Glatting, G., Kotzerke, J., Kinzl, L., & Reske, S. N. (1998) · PubMed · Cited by 198
(1993) · PubMed · Cited by 197
ZHUANG, H., DUARTE, P. S., POURDEHAND, M., SHNIER, D., & ALAVI, A. (2000) · Clinical Nuclear Medicine · doi:10.1097/00003072-200004000-00009 · Cited by 196 · cited 3×
“who have been treated with antibiotics prior to imaging (177).”
BackgroundMethodSelf-citationDe Winter, F., Vogelaers, D., Gemmel, F., & Dierckx, R. (2002) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0708-2 · Cited by 195 · cited 1×
“5 to 2 h, optimal spatial resolution (CT), high target-to-background contrast, and accurate anatomical localization of sites of abnormality (41).”
BackgroundKälicke, T., Schmitz, A., Risse, J. H., Arens, S., Keller, E., Hansis, M., Schmitt, O., Biersack, H. J., & Grünwald, F. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050538 · Cited by 195
Palestro, C. J., Kim, C. K., SWYER, A. J., Capozzi, J. D., SOLOMON, R. W., & Goldsmith, S. J. (1990) · PubMed · Cited by 191
Meller, J., Altenvoerde, G., Munzel, U., Jauho, A., Behe, M., Gratz, S., Luig, H., & Becker, W. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000341 · Cited by 182 · cited 4×
“FDG-PET allows the identification of inflammatory and cancerous disorders as the underlying cause of FUO in most patients and has been shown to detect infectious and inflammatory disease processes that were undetected when conventional scintigraphic techniques or MRI was used (20, 35, 98, 106, 166, 170).”
BackgroundInfluentialA meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases
Isasi, C. R., Moadel, R. M., & Blaufox, M. D. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-3291-7 · Cited by 181 · cited 1×
“This methodology was used for the diagnosis, staging, treatment planning, and treatment monitoring of malignant disease (49, 68, 69, 88, 89, 180).”
MethodFever of unknown origin. An old friend revisited
Petersdorf, R. G. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.1.21 · Cited by 174
Takayasu's arteritis--recent advances in imaging offer promise
Andrews, J., & Mason, J. C. (2007) · Rheumatology · doi:10.1093/rheumatology/kel323 · Cited by 174
Structured treatment interruption in patients with alveolar echinococcosis
Reuter, S., Buck, A., Manfras, B., Kratzer, W., Seitz, H. M., Darge, K., Reske, S. N., & Kern, P. (2004) · Hepatology · doi:10.1002/hep.20078 · Cited by 171 · cited 2×
“FDG-PET has also been reported to be reliable for assessing metabolic activity and for detecting relapses of infection in patients with alveolar echinococcosis (134).”
BackgroundMethodZhuang, H., Yu, J. Q., & Alavi, A. (2005) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.07.005 · Cited by 170 · cited 1×
“For example, FUO can be caused by sarcoidosis (29, 53, 97) and vasculitis (34, 47, 116, 138), both of which can be detected and characterized with FDG-PET at various stages of the disease (2, 10, 12, 16, 23, 39, 61, 91, 92, 109, 175, 183).”
BackgroundSelf-citationBasu, S., Chryssikos, T., Houseni, M., Scot Malay, D., Shah, J., Zhuang, H., & Alavi, A. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e328174447f · Cited by 163 · cited 1×
“For example, FUO can be caused by sarcoidosis (29, 53, 97) and vasculitis (34, 47, 116, 138), both of which can be detected and characterized with FDG-PET at various stages of the disease (2, 10, 12, 16, 23, 39, 61, 91, 92, 109, 175, 183).”
BackgroundSelf-citationReinartz, P., Mumme, T., Hermanns, B., Cremerius, U., Wirtz, D. C., Schaefer, W. M., Niethard, F.-U., & Buell, U. (2005) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.87b4.14954 · Cited by 159
Chacko, T. K., Zhuang, H. M., Stevenson, K. S., MOUSSAVIAN, B., & Alavi, A. A. (2002) · Nuclear Medicine Communications · doi:10.1097/00006231-200209000-00008 · Cited by 156 · cited 1×
“(26) studied the location and intensity of FDG uptake in 41 total hip prostheses from 32 patients with complete clinical follow-up.”
BackgroundSelf-citationImaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients.
Dumarey, N., Egrise, D., Blocklet, D., Stallenberg, B., Remmelink, M., del Mármol, V., Simaeys, G. V., Jacobs, F., & Goldman, S. (2006) · PubMed · Cited by 156
Ozsahin, H., von Planta, M., Müller, I., Steinert, H. C., Nadal, D., Lauener, R., Tuchschmid, P., Willi, U. V., Ozsahin, M., Crompton, N. E. A., et al. (1998) · Blood · doi:10.1182/blood.v92.8.2719 · Cited by 151
Chakrabarti, R., Jung, C. Y., Lee, T. P., Liu, H., & Mookerjee, B. K. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.2660 · Cited by 149 · cited 1×
“The enhanced uptake of FDG in activated inflammatory cells such as lymphocytes or macrophages is related to significantly increased levels of glycolysis as a result of increased numbers of cell surface glucose transporters, particularly after cellular stimulation by multiple cytokines (27, 111, 150, 171).”
BackgroundThe diabetic foot: initial experience with 18F-FDG PET/CT.
Keidar, Z., Militianu, D., Melamed, E. A., Bar‐Shalom, R., & Israel, O. (2005) · PubMed · Cited by 149
Fishbane, S. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00373-1 · Cited by 142
Alavi, A. A., Newberg, A. B., Souder, E., & Berlin, J. A. (1993) · PubMed · Cited by 141
Self-citationPositron emission tomography imaging of regional cerebral glucose metabolism
Alavi, A. A., Dann, R., Chawluk, J. B., Alavi, J. Β., Kushner, M., & Reivich, M. (1986) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(86)80002-2 · Cited by 134 · cited 1×
“In addition, this agent was used to investigate the effects of a multitude of neuropsychiatric disorders on regional brain function (3, 4, 6, 8).”
BackgroundSelf-citationBleeker‐Rovers, C. P., Bredie, S. J. H., van der Meer, J. W. M., Corstens, F. H. M., & Oyen, W. J. G. (2003) · PubMed · Cited by 129
Diagnosing Foot Infection in Diabetes
Williams, D. T., Hilton, J. R., & Harding, K. G. (2004) · Clinical Infectious Diseases · doi:10.1086/383267 · Cited by 127 · cited 1×
“Furthermore, a large proportion of diabetic patients with deep foot infection do not have leukocytosis in spite of active disease (164).”
BackgroundMahfouz, T. H., Miceli, M. H., Saghafifar, F., Stroud, S. C., Jones-Jackson, L. B., Walker, R. C., Grazziutti, M., Purnell, G. L., Fassas, A., Tricot, G. J. K., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.8581 · Cited by 127 · cited 2×
“patients with severe neutropenia and lymphopenia (101).”
BackgroundPersistent non-specific FDG uptake on PET imaging following hip arthroplasty
Zhuang, H., Chacko, T. K., Hickeson, M. P., Stevenson, K. S., Feng, Q., Ponzo, F., Garino, J. P., & Alavi, A. A. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0886-2 · Cited by 125 · cited 2×
“Interestingly, some degree of inflammation around the femoral neck component, which is generally noninfectious in nature, is frequently noted (176).”
BackgroundSelf-citationFuster, D., Chiang, S. B., Johnson, G. R., Schuchter, L. M., Zhuang, H., & Alavi, A. A. (2004) · PubMed · Cited by 125
Self-citationXiu, Y., Bhutani, C., Dhurairaj, T., Yu, J. Q., Dadparvar, S., Reddy, S., Kumar, R., Yang, H., Alavi, A. A., & Zhuang, H. (2007) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000252457.54929.b7 · Cited by 124 · cited 1×
“This is due to the observation that standardized uptake values (SUVs) of inflammatory and nonneoplastic lesions tend to remain stable or decrease, while those of the malignant lesions tend to increase over time (33, 169, 181).”
BackgroundSelf-citationBleeker‐Rovers, C. P., de Sévaux, R. G. L., van Hamersvelt, H. W., Corstens, F. H. M., & Oyen, W. J. G. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00368-8 · Cited by 124 · cited 1×
“In a clinical study, FDG uptake returned to normal levels after successful antibiotic therapy for hepatic cyst infection (18), after antifungal therapy for a lung abscess caused by candidal infection (19), and after therapy for Pneumocystis carinii pneumonia (167) (Fig.”
BackgroundBone scan, gallium scan, and hip aspiration in the diagnosis of infected total hip arthroplasty
Kraemer, W. J., Saplys, R., Waddell, J. P., & Morton, J. (1993) · The Journal of Arthroplasty · doi:10.1016/0883-5403(93)90008-r · Cited by 123 · cited 1×
“and bone scintigraphy, have been employed to differentiate between these two conditions (85, 123, 142).”
BackgroundGuest editorial: The conception of FDG-PET imaging
Alavi, A. A., & Reivich, M. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.29269 · Cited by 120
Self-citationFDG-PET Finding in Early-Phase Takayasu Arteritis
Hara, M., Goodman, P. C., & Leder, R. A. (1999) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199901000-00004 · Cited by 120 · cited 1×
“For example, FUO can be caused by sarcoidosis (29, 53, 97) and vasculitis (34, 47, 116, 138), both of which can be detected and characterized with FDG-PET at various stages of the disease (2, 10, 12, 16, 23, 39, 61, 91, 92, 109, 175, 183).”
BackgroundHeald, A. E., Hoffman, J. M., Bartlett, J. A., & Waskin, H. A. (1996) · International Journal of STD & AIDS · doi:10.1258/0956462961918239 · Cited by 120 · cited 1×
“(63) attempted to differentiate CNS lesions in AIDS patients by using both a qualitative visual score and a semiquantitative count ratio through comparisons of the CNS lesions with the contralateral brain.”
MethodApplications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection
Chacko, T. K., ZHUANG, H., Nakhoda, K. Z., MOUSSAVIAN, B., & Alavi, A. A. (2003) · Nuclear Medicine Communications · doi:10.1097/00006231-200306000-00002 · Cited by 116 · cited 1×
“(25) noted that in contrast to conventional nuclear medicine VOL.”
ResultSelf-citationScher, D. M., Pak, K., Lonner, J. H., Finkel, J. E., Zuckerman, J. D., & Cesare, P. E. D. (2000) · The Journal of Arthroplasty · doi:10.1016/s0883-5403(00)90555-2 · Cited by 109 · cited 2×
“(142) reported a sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy of (111)In-labeled WBC imaging in the diagnosis of infected total hip and knee prostheses of 77%, 86%, 54%, 95%, and 84%, respectively.”
BackgroundStumpe, K. D. M., Renner, E. C., Kuenzle, A. K., Grimm, F., Kadry, Z., Clavien, P., Deplazes, P., von Schulthess, G. K., Muellhaupt, B., Ammann, R., et al. (2007) · Infection · doi:10.1007/s15010-007-6133-9 · Cited by 109 · cited 1×
“FDG-PET has also been proposed as a tool to evaluate the effectiveness of therapy for human alveolar echinococcosis (43, 134, 154).”
MethodFDG-PET Findings of Vertebral Compression Fractures in Osteoporosis: Preliminary Results
Schmitz, A., Risse, J. H., Textor, J., Zander, D., Biersack, H.-J., Schmitt, O., & PALMEDO, H. (2002) · Osteoporosis International · doi:10.1007/s001980200103 · Cited by 107
The diabetic foot: the scope of the problem.
Boulton, A. J. M., & Vileikytė, L. (2000) · PubMed · Cited by 102
Netea, M. G., Brouwer, A. E., Hoogendoorn, E. H., Van der Meer, J. W. M., Koolen, M., Verweij, P. E., & Kullberg, B. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425121 · Cited by 100
Reuter, S., Schirrmeister, H., Kratzer, W., Dreweck, C. M., Reske, S. N., & Kern, P. (1999) · Clinical Infectious Diseases · doi:10.1086/313438 · Cited by 97 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundQuantifying Pulmonary Inflammation in Cystic Fibrosis with Positron Emission Tomography
Chen, D. L., Ferkol, T. W., Mintun, M. A., Pittman, J. E., Rosenbluth, D., & Schuster, D. P. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-934oc · Cited by 97 · cited 1×
“FDG-PET has also been used to determine the inflammatory burden of disease in patients with cystic fibrosis (32).”
MethodZHUANG, H. M., CORTÉS-BLANCO, A., POURDEHNAD, M., ADAM, L.-E., YAMAMOTO, A. J., MARTÍNEZ-LÁZARO, R., LEE, J. H., LOMAN, J. C., ROSSMAN, M. D., & ALAVI, A. (2001) · Nuclear Medicine Communications · doi:10.1097/00006231-200110000-00011 · Cited by 96 · cited 2×
“In general, the quality of FDG-PET images for assessing infection is optimal when serum glucose levels are less than 250 mg/dl (184).”
BackgroundMethodSelf-citationMR Imaging of the Diabetic Foot: Diagnostic Challenges
Chatha, D. S., Cunningham, P. M., & Schweitzer, M. E. (2005) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2005.02.008 · Cited by 86 · cited 1×
“Those authors also concluded that FDG-PET can provide an accurate assessment of patients with metal implants, which may otherwise limit evaluation by MRI, and that FDG-PET can correctly distinguish osteomyelitis from Charcot osteoarthropathy (31, 66).”
BackgroundMumme, T., Reinartz, P., Alfer, J., Müller-Rath, R., Buell, U., & Wirtz, D. C. (2005) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-005-0810-x · Cited by 86
Whole-body positron emission tomography in patients with HIV-1 infection
Scharko, A. M., Perlman, S. B., Pyzalski, R. W., Graziano, F. M., Sosman, J. M., & Pauza, C. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14366-8 · Cited by 85 · cited 1×
“(141) noted an association between the clinical FIG.”
BackgroundComparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.
Lindholm, P., Leskinen-Kallio, S., Minn, H. R. I., Bergman, J., Haaparanta‐Solin, M., Lehikoinen, P., Någren, K., Ruotsalainen, U., Teräs, M., & Joensuu, H. (1993) · PubMed · Cited by 79
Brust, D. G., Polis, M. A., Davey, R. T., Hahn, B. K., Bacharach, S. L., Whatley, M. A., Fauci, A. S., & Carrasquillo, J. A. (2006) · AIDS · doi:10.1097/01.aids.0000222070.52996.76 · Cited by 78 · cited 1×
“Healthy HIV-infected subjects with suppressed viral loads and HIV-negative individuals have no or little FDG nodal accumulation or any other hypermetabolic areas, whereas HIVviremic subjects with early or advanced disease have increased FDG uptake in peripheral nodes (24).”
BackgroundSorbara, L. R., Maldarelli, F. M., Chamoun, G., Schilling, B., Chokekijcahi, S., Staudt, L. M., Mitsuya, H., Simpson, I. A., & Zeichner, S. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7275-7279.1996 · Cited by 73 · cited 1×
“The enhanced uptake of FDG in activated inflammatory cells such as lymphocytes or macrophages is related to significantly increased levels of glycolysis as a result of increased numbers of cell surface glucose transporters, particularly after cellular stimulation by multiple cytokines (27, 111, 150, 171).”
BackgroundComparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing.
Koort, J. K., Mäkinen, T. J., Knuuti, J. M., Jalava, J., & Aro, H. T. (2004) · PubMed · Cited by 70
Leeuw, D. K., Bijl, M., & Jager, P. L. (2004) · PubMed · Cited by 70
Sarcoidosis Demonstrated by FDG PET Imaging With Negative Findings on Gallium Scintigraphy
Xiu, Y., Yu, J. Q., Cheng, E., Kumar, R., Alavi, A. A., & Zhuang, H. (2005) · Clinical Nuclear Medicine · doi:10.1097/00003072-200503000-00013 · Cited by 68 · cited 1×
“FDG-PET allows the identification of inflammatory and cancerous disorders as the underlying cause of FUO in most patients and has been shown to detect infectious and inflammatory disease processes that were undetected when conventional scintigraphic techniques or MRI was used (20, 35, 98, 106, 166, 170).”
Self-citationDefawe, O., Hustinx, R., Defraigne, J. O., Limet, R., & Sakalihasan, N. (2005) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000159681.24833.95 · Cited by 62 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundPET: a revolution in medical imaging
Alavi, A. A., Lakhani, P. C., Mavi, A., Kung, J. W., & Zhuang, H. (2004) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.08.012 · Cited by 61 · cited 1×
“However, both CT and MRI are generally limited by their poor sensitivity for detecting early stages of disease at the molecular and cellular levels where no alterations in gross organ and tissue structures have occurred (5).”
BackgroundSelf-citationHakim, S. G., Bruecker, C. W. R., Jacobsen, H. C., Hermes, D., Lauer, I., Eckerle, S., Froehlich, A., & Sieg, P. (2006) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2006.03.029 · Cited by 60 · cited 3×
“6%, compared to a specificity of 80% for FDG-PET (59).”
BackgroundResultInfluentialSahlmann, C. O., Siefker, U., Lehmann, K., & Meller, J. (2004) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000135600.23896.9d · Cited by 56 · cited 1×
“Controlled animal experiments further clarified the phenomenon of increased glycolysis in inflamed tissues and demonstrated the superiority of FDG-PET compared to other nuclear medicine techniques in such settings (72, 84, 139, 181).”
ResultDadparvar, S., Anderson, G. S., Bhargava, P., Guan, L., Reich, P., Alavi, A. A., & Zhuang, H. (2003) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000093284.54060.aa · Cited by 55 · cited 1×
“FDG-PET allows the identification of inflammatory and cancerous disorders as the underlying cause of FUO in most patients and has been shown to detect infectious and inflammatory disease processes that were undetected when conventional scintigraphic techniques or MRI was used (20, 35, 98, 106, 166, 170).”
Self-citationKrupnick, A. S., Lombardi, J. V., Engels, F. H. C., Kreisel, D., Zhuang, H., Alavi, A. A., & Carpenter, J. P. (2003) · Vascular and Endovascular Surgery · doi:10.1177/153857440303700509 · Cited by 55
Self-citationIs there a role for FDG PET imaging in the management of patients with sarcoidosis?
Alavi, A. A., Buchpiguel, C. A., & Loessner, A. (1994) · PubMed · Cited by 53
Self-citationGüngör, T., Engel-Bicik, I., Eich, G., Willi, U. V., Nadal, D., Hossle, J. P., Seger, R. A., & Steinert, H. C. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.4.341 · Cited by 53
Miceli, M. H., Jackson, L. B. J., Walker, R. C., Talamo, G., Barlogie, B., & Anaissie, E. J. (2004) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000130247.37315.66 · Cited by 52 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundNarrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy
Conrad, G. R., & Sinha, P. (2003) · Nuclear Medicine Communications · doi:10.1097/00006231-200311000-00002 · Cited by 52 · cited 1×
“This is due to the observation that standardized uptake values (SUVs) of inflammatory and nonneoplastic lesions tend to remain stable or decrease, while those of the malignant lesions tend to increase over time (33, 169, 181).”
BackgroundDiagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography
Bleeker‐Rovers, C. P., Warris, A., Drenth, J. P. H., Corstens, F. H. M., Oyen, W. J. G., & Kullberg, B.-J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01155.x · Cited by 46 · cited 1×
“In a clinical study, FDG uptake returned to normal levels after successful antibiotic therapy for hepatic cyst infection (18), after antifungal therapy for a lung abscess caused by candidal infection (19), and after therapy for Pneumocystis carinii pneumonia (167) (Fig.”
BackgroundAlavi, A. A., Reivich, M., Ferris, S. H., Christman, D. R., Fowler, J. S., MacGregor, R. R., Farkas, T., Greenberg, J. H., Dann, R., & Wolf, A. P. (1982) · Experimental brain research. Supplementum · doi:10.1007/978-3-642-68507-1_26 · Cited by 43 · cited 1×
“In addition, this agent was used to investigate the effects of a multitude of neuropsychiatric disorders on regional brain function (3, 4, 6, 8).”
BackgroundSelf-citationPET/CT Using 2-Deoxy-2-[18F]Fluoro-D-Glucose for the Evaluation of Suspected Infected Vascular Graft
Keidar, Z. (2003) · Molecular Imaging and Biology · doi:10.1016/s1536-1632(03)00035-0 · Cited by 40 · cited 1×
“Furthermore, FDG-PET/CT is reported to have an even better accuracy to detect vascular graft infection (78).”
BackgroundAydın, A., Hickeson, M. P., Yu, J. Q., Zhuang, H., & Alavi, A. A. (2005) · Clinical Nuclear Medicine · doi:10.1097/00003072-200503000-00003 · Cited by 39 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundSelf-citationSturm, E., Rings, E. H. H. M., Schölvinck, E. H., Gouw, A. S. H., Porte, R. J., & Pruim, J. (2006) · Liver Transplantation · doi:10.1002/lt.20922 · Cited by 38 · cited 1×
“(155), FDG-PET was utilized to evaluate 13 such patients.”
MethodBennink, R. J., Peeters, M., Rutgeerts, P., & Mortelmans, L. (2004) · PubMed · Cited by 36
Nuclear medicine imaging in fever of unknown origin.
Peters, A. M. (1999) · PubMed · Cited by 35
FDG-PET Imaging in Pneumocystis carinii Pneumonia
Win, Z., Todd, J., & AL-NAHHAS, A. M. (2005) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000178784.58278.36 · Cited by 33 · cited 2×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundChronic Cholecystitis Detected by FDG-PET
Yu, J. Q., Kung, J. W., Potenta, S. E., Xiu, Y., Alavi, A. A., & Zhuang, H. (2004) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000132952.14515.9c · Cited by 33 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundSelf-citationInvestigation of thyroid, head, and neck cancers with PET
Zhuang, H., Kumar, R., Mandel, S. J., & Alavi, A. A. (2004) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2004.07.006 · Cited by 31 · cited 1×
“This methodology was used for the diagnosis, staging, treatment planning, and treatment monitoring of malignant disease (49, 68, 69, 88, 89, 180).”
MethodSelf-citationFDG PET Imaging of Acute Cholecystitis
Kitazono, M. T., & Colletti, P. M. (2005) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000191567.16067.83 · Cited by 31 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundIncidental Detection of Bilateral Elastofibroma Dorsi With F-18 FDG PET/CT
Wasyliw, C. W., & Caride, V. J. (2005) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000178786.99368.1d · Cited by 27 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundInfluentialAchilles Tendonitis Detected by FDG-PET
Huang, S. S.-L., Yu, J. Q., Chamroonrat, W., Alavi, A. A., & Zhuang, H. (2006) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000200463.66611.66 · Cited by 26 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundSelf-citationBrust, D. G., Polis, M. A., Davey, R. T., Hahn, B. K., Bacharach, S. L., Whatley, M. A., Fauci, A. S., & Carrasquillo, J. A. (2006) · AIDS · doi:10.1097/01.aids.0000210603.40267.29 · Cited by 26
Schmitz, A., Risse, H., Kälicke, T., Grünwald, F., & Schmitt, O. (2000) · Zeitschrift für Orthopädie und ihre Grenzgebiete · doi:10.1055/s-2000-10169 · Cited by 24
FDG Uptake in a Catheter-Related Thrombus Simulating Relapse of Lymphoma
steen, A.-K. S., Celsing, F., & Jacobsson, H. (2005) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000159680.66566.b7 · Cited by 22 · cited 1×
“Although infectious or inflammatory processes frequently pose a diagnostic challenge in the evaluation of patients with cancer (148), the possibility that malignant lesions may also mimic infectious or inflammatory disease (9, 28) should not be overlooked.”
BackgroundWyss, M. T., Honer, M., Spaeth, N., Gottschalk, J., Ametamey, S. M., Weber, B., von Schulthess, G. K., Buck, A., & Kaim, A. H. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.06.001 · Cited by 18 · cited 1×
“Animal experiments have also shown that FDG-PET is accurate for monitoring responses following antibiotic therapy in the setting of soft tissue infection (168).”
BackgroundAtlantoaxial Osteoarthritis in Rheumatoid Arthritis: FDG PET/CT Findings
Kaneta, T., Hakamatsuka, T., Yamada, T., Kei, T., Sato, A., Higano, S., Ito, H., Fukuda, H., Takahashi, S., & Yamada, S. (2006) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000204124.79497.bb · Cited by 17 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundReddy, M. P., & Ramaswamy, M. R. (2005) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000156798.59230.2e · Cited by 14 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundPulmonary Clostridium perfringens Infection Detected by FDG Positron Emission Tomography
Zhuang, H., Duarte, P. S., Rebenstock, A., Feng, Q., & Alavi, A. A. (2003) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000067521.85209.c1 · Cited by 12 · cited 1×
“Certain conditions have been shown to increase FDG uptake: (i) benign infection of the lungs or mediastinum (100, 102, 146, 167, 179), appendix (82), gall bladder (80, 173), and many other organs (64, 70, 114, 135, 140); (ii) inflammation without infection, including sarcoidosis (55), pulmonary artery thrombosis (50),…”
BackgroundSelf-citation
Cited by
Basu, S., Chryssikos, T., Moghadam-Kia, S., Zhuang, H., Torigian, D. A., & Alavi, A. (2009) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.08.004 · Cited by 254
Self-citation
Metadata
- Authors
- Kumar, R., Basu, S., Torigian, D., Anand, V., Zhuang, H., & Alavi, A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2008-01
- Volume
- 21
- Issue
- 1
- Pages
- 209-224
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2140401778
- Cited by
- 180
- References
- 106
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.